Cite
MLA Citation
Felix Lu et al.. “Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.” Clinical and translational gastroenterology, vol. 11, no. 12, 2020, pp. e00271–. http://access.bl.uk/ark:/81055/vdc_100168328427.0x000022